Gold Entertainment to issue 100K Series B preferred shares for controlling stake in DEVON Testing

GOLD ENTERPRISE GROUP INC

Issued 100,000 Series B Preferred shares as payment to acquire controlling shares of DEVON MEDICAL PRODUCTS, INC.
Authorized Preferred B shares increased to 500,000; amended articles filed with Florida.
Agreement effective February 1, 2022; reported on Form 8-K dated July 30, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.